Pharmafile Logo

News and Press Releases

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics 11 March 2024 -- Dundee, UK --...

Category: Drug Discovery
Posted: March 11, 2024

Ubiquigent
services@ubiquigent.com
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK

Aston University and University of Warwick team wins £1.8m for research to aid drug discovery and sustainable chemical production

The team will engineer cells to make membrane proteins efficiently The proteins will be used for drug discovery and screening, and as catalysts in sustainable chemical production The £1.8m Engineering...

Category: Drug Discovery
Posted: February 12, 2024

Aston University
Aston University Birmingham B4 7ET UK

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Sponsored PhD student will join Professor Ed Tate’s group at Imperial College London, UK, in the EPSRC Centre for Doctoral Training in Chemical Biology Project aims to develop the next...

Category: Biotechnology, Drug Discovery
Posted: October 4, 2023

Ubiquigent
services@ubiquigent.com
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK